Echocardiography Course undertaken at Richmond Pharmacology
Posted:
13
March 2019
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner and Dr Simon Coates, Research Physician respectively, all began in-house training...
Echocardiography Course undertaken at Richmond Pharmacology
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner and Dr Simon Coates, Research Physician respectively, all began inhouse training for a BSE Level 1 Echocardiography this February.A Level 1 Echocardiography is designed to be accessible to echocardiography practitioners from a wide variety of backgrounds, and has, at its ultimate aim, the achievement and maintenance of high standards of clinical echocardiography to rule out life threatening and immediately reversible pathology in a time frame appropriate to the acute emergency patient.The course will run over a 2-year duration and qualify the individuals for a BSE Level 1 Qualification.
Futureproofing early phase clinical research for the next generation of investigators.
March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions
Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.